Claims for Patent: 8,293,742

Summary for Patent: 8,293,742

Title:	Preferential vasoconstriction compositions and methods of use
Abstract:	The invention generally relates to compositions and methods for preferential vasoconstriction of smaller blood vessels relative to larger blood vessels. The compositions comprise highly selective alpha-2 adrenergic receptor agonists, at low concentrations, such as below 0.05% weight by volume. The compositions preferably comprise brimonidine. The compositions preferably have pH between about 5.5 and about 6.5.
Inventor(s):	Horn; Gerald (Deerfield, IL)
Assignee:	Alpha Synergy Development, Inc. (Dana Point, CA)
Application Number:	12/460,941
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,293,742
Patent Claims:	1. A method for reducing eye redness consisting essentially of administering brimonidine to a patient having an ocular condition, wherein brimonidine is present at a concentration between about 0.001% weight by volume and about 0.05% weight by volume. 2. The method of claim 1, wherein brimonidine is present at a concentration between about 0.001% to about 0.025% weight by volume. 3. A method for reducing eye redness consisting essentially of topically administering to a patient having an ocular condition a composition consisting essentially of brimonidine into ocular tissue, wherein pH of said composition is between about 5.5 and about 6.5, wherein said brimonidine concentration is between about 0.001% and about 0.025% weight by volume and wherein said composition is formulated as an ocular drop. 4. The method of claim 3, wherein said composition is topically administered within about 24 hours after a Lasik surgery on said patient. 5. The method according to claim 1, wherein said ocular condition is chronic red eye. 6. The method according to claim 3, wherein said ocular condition is chronic red eye.